Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Expert Review of Gastroenterology & Hepatology|July 15, 2017
Comparative efficacy of vasoconstrictor therapies for type 1 hepatorenal syndrome: a network meta-analysisJi-Na Zheng, Yi-Jing Han, Tian-Tian Zou, et al.
Gene|May 6, 2014
Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantationLing-Fei Li, Ke-Qing Shi, Yi-Qian Lin, et al.
Oncotarget|June 11, 2015
Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysisGui-Qi Zhu, Ke-Qing Shi, Hua-Jian Yu, et al.
Expert Review of Gastroenterology & Hepatology|July 30, 2015
New advances in liver decellularization and recellularization: innovative and critical technologiesYi-Qian Lin, Li-Ren Wang, Jiang-Tao Wang, et al.
Plos One|November 9, 2016
Establishment and Validation of GV-SAPS II Scoring System for Non-Diabetic Critically Ill PatientsWen-Yue Liu, Shi-Gang Lin, Gui-Qi Zhu, et al.
Scientific Reports|September 20, 2016
Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular CarcinomaYao-Yao Zhou, Gui-Qi Zhu, Tian Liu, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Hit-to-Lead studies: the discovery of potent adamantane amide P2X7 receptor antagonistsAndrew Baxter, Janice Bent, Keith Bowers, et al.
Medicine|March 20, 2015
Network meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosisGui-Qi Zhu, Ke-Qing Shi, Sha Huang, et al.
Expert Opinion on Therapeutic Targets|October 1, 2015
Serum uric acid: a new therapeutic target for nonalcoholic fatty liver diseaseDan-Qin Sun, Sheng-Jie Wu, Wen-Yue Liu, et al.
Cytotherapy|November 25, 2015
Kidney bioengineering in regenerative medicine: An emerging therapy for kidney diseaseYi-Qian Lin, Li-Ren Wang, Liang-Liang Pan, et al.
Pageof 8